|
|
Volumn 22, Issue 4, 2004, Pages 363-364
|
|
Erbitux diagnostic latest adjunct to cancer therapy.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
LIGAND;
MONOCLONAL ANTIBODY;
TUMOR MARKER;
ADJUVANT CHEMOTHERAPY;
ARTICLE;
BIOTECHNOLOGY;
COLORECTAL TUMOR;
HUMAN;
METABOLISM;
METHODOLOGY;
SENSITIVITY AND SPECIFICITY;
ANTIBODIES, MONOCLONAL;
BIOLOGICAL MARKERS;
BIOTECHNOLOGY;
CHEMOTHERAPY, ADJUVANT;
COLORECTAL NEOPLASMS;
HUMANS;
LIGANDS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
SENSITIVITY AND SPECIFICITY;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 4444284248
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt0404-363 Document Type: Article |
|
Times cited : (14)
|
|
References (0)
|
